Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam S Sperling

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Blood|July 31, 2025
Two clones, one niche: how CH shapes the MM microenvironmentAdam S Sperling
Blood Advances|October 24, 2024
Cytopenias in BCMA CAR T: unraveling inflammatory mechanismsAdam S Sperling
Cell Chemical Biology|August 19, 2022
Repurposing the repurposed: thalidomide analogs as immune stimulants to overcome T cell exhaustionMikołaj Słabicki, Adam S Sperling
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Histone H3 N-terminus regulates higher order structure of yeast heterochromatinAdam S Sperling, Michael Grunstein
Hematology/Oncology Clinics of North America|August 10, 2023
Chimeric Antigen Receptor T Cells in Multiple MyelomaParth Shah, Adam S Sperling
Blood|August 12, 2017
Prevalent premalignancyAdam S Sperling, Benjamin L Ebert
Journal of the National Cancer Institute|September 11, 2019
CHIPing Away at Breast CancerAdam S Sperling, Benjamin L Ebert
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2021
Facts and Hopes in Multiple Myeloma ImmunotherapyAdam S Sperling, Kenneth C Anderson
Nature Reviews. Clinical Oncology|March 3, 2021
Cancer therapies based on targeted protein degradation - lessons learned with lenalidomideMax Jan, Adam S Sperling, Benjamin L Ebert
Nature Reviews. Cancer|November 12, 2016
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemiaAdam S Sperling, Christopher J Gibson, Benjamin L Ebert
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Blood|July 31, 2025
Two clones, one niche: how CH shapes the MM microenvironmentAdam S Sperling
Blood Advances|October 24, 2024
Cytopenias in BCMA CAR T: unraveling inflammatory mechanismsAdam S Sperling
Cell Chemical Biology|August 19, 2022
Repurposing the repurposed: thalidomide analogs as immune stimulants to overcome T cell exhaustionMikołaj Słabicki, Adam S Sperling
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Histone H3 N-terminus regulates higher order structure of yeast heterochromatinAdam S Sperling, Michael Grunstein
Hematology/Oncology Clinics of North America|August 10, 2023
Chimeric Antigen Receptor T Cells in Multiple MyelomaParth Shah, Adam S Sperling
Blood|August 12, 2017
Prevalent premalignancyAdam S Sperling, Benjamin L Ebert
Journal of the National Cancer Institute|September 11, 2019
CHIPing Away at Breast CancerAdam S Sperling, Benjamin L Ebert
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2021
Facts and Hopes in Multiple Myeloma ImmunotherapyAdam S Sperling, Kenneth C Anderson
Nature Reviews. Clinical Oncology|March 3, 2021
Cancer therapies based on targeted protein degradation - lessons learned with lenalidomideMax Jan, Adam S Sperling, Benjamin L Ebert
Nature Reviews. Cancer|November 12, 2016
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemiaAdam S Sperling, Christopher J Gibson, Benjamin L Ebert
Pageof 9